InterVenn Biosciences has torn up its 10-year-lease for a 142,000-square-foot building in South San Francisco. The biotech startup based in the city has canceled its lease for the office and research building at 499 Forbes Boulevard, the San Francisco Business Times reported. The lease was signed a year ago with San Francisco-based Aralon Properties. Terms [...]The post InterVenn scrubs lease for offices and labs in South SF appeared first on The Real Deal.
InterVenn is a California-based AI glycoproteomics platform that offers solutions such as biomarker research and liquid biopsy assay development for the healthcare industry.